Compare MEDTRONIC INC vs ZIMMER BIOMET in Bone Growth Stimulator Products

Product Maturity/ Has the company launch an innovative Technology in last three years?
Yes
Product Maturity/ In which regions do you offer your products?
APAC
Product Maturity/ In which regions do you offer your products?
APAC
Product Maturity/ How do you deliver your solutions to your customers?
Directly
Product Maturity/ How do you deliver your solutions to your customers?
Directly
Product Maturity/ In which regions do you offer your products?
EU

Product Maturity/ How do you deliver your solutions to your customers?
Through Partners / Third-Party Vendors
Product Maturity/ Has the company launch an innovative Technology in last three years?
Yes
Product Maturity/ Which of the following end-user(s) does the solution cater to?
Home care
Product Maturity/ Which of the following end-user(s) does the solution cater to?
Academic & Research Institutes and CRO
Product Maturity/ For which of the following end-users do you provide your solution/product?
Home-care
Product Maturity/ Which of the following applications does your solution/product cater to? Can you please provide a brief about the same?
Oral-maxillofacial surgery

Capacitive coupling (CC) devices
0
5
Pulsed electromagnetic field (PEMF) devices
0
5
Implanted electrical bone growth stimulators
0
5
Bone morphogenetic proteins (BMP)
5
0
Platelet-Rich Plasma (PRP)
0
5

Hospitals
5
5
Orthopedic clinics
5
5
Home-care
0
5
Academic & Research Institutes and CROs
5
5

Spine Fusion
5
5
Bone fracture
5
5
Oral-maxillofacial surgery
5
0
Others
5
5

Yes
5
0

Directly
5
5
Through Partners / Third-Party Vendors
0
5

Hospital
5
5
Orthopedic clinic
5
5
Home care
0
5
Academic & Research Institutes and CRO
5
0

NA
5
5
EU
5
5
APAC
5
5
RoW
5
5

direct presence - North America
5
5
direct presence - Europe
5
5
direct presence - Asia-Pacific
5
5
direct presence - RoW
5
5

North America
5
5
Europe
5
5
Asia-Pacific
5
5
RoW
5
5

businesss segments your company have
3.65
3.25

brands your compnay have
1.05
3.25

Total revenue for FY2016
5
1.65

Mergers and acquisitions undertaken in the past one year
0
1.6